Prevalence of common thrombophilia markers and risk factors in Indian patients with primary venous thrombosis
Keywords:
Asian continental ancestry group, Venous thrombosis, Risk factors, Thrombophilia, Antibodies, anticardiolipinAbstract
CONTEXT AND OBJECTIVE: Venous thrombosis occurs as a result of interaction of genetic and acquired factors including activated protein C resistance (APC-R), fibrinogen levels, antithrombin, protein C, protein S, lupus anticoagulants and anticardiolipin antibodies. This study was aimed at determining the prevalence of these common thrombophilia markers in Asian Indians with primary venous thrombosis. DESIGN AND SETTING: This was a cross-sectional study carried out in Mumbai. METHODS: Samples from 78 patients with a confirmed diagnosis of venous thrombosis and 50 controls were tested. Semi-quantitative estimation (functional assays) of protein C, protein S and antithrombin was performed. Quantitative estimation of fibrinogen was done using the Clauss method. Lupus anticoagulants were screened using lupus-sensitive activated partial thromboplastin time and β2-glycoprotein-I dependent anticardiolipin antibodies were estimated by ELISA. APC-R was measured using a clotting-based method with factor V deficient plasma and Crotalus viridis venom. Statistical analysis was performed using Epi-info (version 6). RESULTS: The popliteal vein was the most commonly involved site. Forty-four samples (56%) gave abnormal results. The commonest were elevated fibrinogen and APC-R (17.9% each), followed by low protein S (16.6%). CONCLUSIONS: This study confirms the literature findings that fibrinogen level estimation and screening for APC-R are important for the work-up on venous thrombosis patients since these, singly or in combination, may lead to a primary thrombotic episode. The frequency of the other thrombophilia markers was higher among the patients than among the controls, but without statistically significant difference.
Downloads
References
Angles-Cano E, Sultan Y, Clauvel JP. Predisposing factors to thrombosis in systemic lu- pus erythematosus: possible relation to endothelial cell damage. J Lab Clin Med. 1979;94(2):312-23.
Bhattacharyya M, Kannan M, Chaudhary VP, Saxena R. Venous thrombosis: preva- lence of prothrombotic defects in north Indian population. Indian J Pathol Microbiol. 2003;46(4):621-4.
Saxena R, Mohanty S, Srivastava A, Choudhry VP, Kotwal J. Pathogenetic factors underlying juvenile deep vein thrombosis (DVT) in Indians. Eur J Haematol. 1999;63(1):26-8.
Ghosh K, Shetty S, Madkaikar M, et al. Venous thromboembolism in young patients from western India: a study. Clin Appl Thromb Hemost. 2001;7(2):158-65.
Khare A, Ghosh K, Shetty S, Kulkarni B, Mohanty D. Combination of thrombophilia markers in acute myocardial infarction of the young. Indian J Med Sci. 2004;58(9):381-8.
Clauss VA. [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol. 1957;17(4):237-46.
Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346(10):752-63.
Persson KE, Dahlbäck B, Hillarp A. Diagnosing protein S deficiency: analytical considera- tions. Clin Lab. 2003;49(3-4):103-10.
Tripodi A, Negri B, Bertina RM, Mannucci PM. Screening for the FV:Q506 mutation-- evalua- tion of thirteen plasma-based methods for their diagnostic efficacy in comparison with DNA analysis. Thromb Haemost. 1997;77(3):436-9.
Svensson PJ, Zöller B, Dahlbäck B. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls. Thromb Haemost. 1997;77(2):332-5.
Pierangeli SS, Gharavi AE, Harris EN. Anticardiolipin testing. In: Khamashta MA, editor. Hu- ghes syndrome: antiphospholipid syndrome. London: Springer-Verlag; 2000. p. 205-13.
Velayuthaprabhu S, Archunan G. Evaluation of anticardiolipin antibodies and antiphosphati- dylserine antibodies in women with recurrent abortion. Indian J Med Sci. 2005;59(8):347- 52.
Srikrishna A, Sitalakshmi S, Devi S, et al. Antiphospholipid antibodies--our experience. In- dian J Pathol Microbiol. 2004;47(2):174-7.
Triplett DA, Brandt JT, Musgrave KA, Orr CA. The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA. 1988;259(4):550-4.
Gladson CL, Scharrer I, Hach V, Beck KH, Griffin JH. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost. 1988;59(1):18-22.
Martinelli I, Manucci PM, De Stefano V, et al. Different risks of thrombosis in four coa- gulation defects associated with inherited thrombophilia: a study of 150 families. Blood. 1998;92(7):2353-8.
Bick RL. Clinical relevance of antithrombin III. Semin Thromb Hemost. 1982;8(4):276-87.
Thaler E, Lechner K. Antithrombin III deficiency and thromboembolism. Clin Haematol. 1981;10(2):369-90.
